Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Immunotherapy for non-oncogene driven resectable non-small cell lung cancer: A true gamechanger but for whom and
A Sachithanandan1,2,3
1Sunway Medical Centre, Division of Cardiothoracic Surgery, Sunway City, Kuala Lumpur, Malaysia. anandsachithanandan@yahoo.com.
Abstract:
No abstract available.
Insights
No abstract available for summarization.
Area of Science:
- No abstract available.
Background:
- No abstract available.
Purpose of the Study:
- No abstract available.
Main Methods:
- No abstract available.
Main Results:
- No abstract available.
Conclusions:
- No abstract available.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...